We are live on ! Find out more
SC

Sessa Capital Portfolio holdings

AUM $5.98B
1-Year Est. Return 99.85%
This Fund
S&P 500
This Quarter Est. Return
-7.36%
1 Year Est. Return
+99.85%
3 Year Est. Return
+146.79%
5 Year Est. Return
+201.69%
10 Year Est. Return
+788.83%
AUM
$1.4B
AUM Growth
-$431M
Cap. Flow
+$43.7M
Cap. Flow %
3.12%
Top 10 Hldgs %
81.3%
Holding
37
New
4
Increased
2
Reduced
4
Closed
6

Top Buys

Rank Stock Value
1
HLN icon
Haleon
HLN
+$110M
2
PRVB
Provention Bio, Inc. Common Stock
PRVB
+$40.5M
3
CRBG icon
Corebridge Financial
CRBG
+$35M
4
EHAB
Enhabit
EHAB
+$16.2M
5
BLCO icon
Bausch + Lomb
BLCO
+$5.71M

Top Sells

Rank Stock Value
1
CC icon
Chemours
CC
+$72.8M
2
CTVA icon
Corteva
CTVA
+$34.8M
3
EMBC icon
Embecta
EMBC
+$31.4M
4
ONL
Orion Office REIT
ONL
+$15.1M
5
ACAD icon
Acadia Pharmaceuticals
ACAD
+$3.51M

Sector Composition

Rank Sector Weight
1 Communication Services 30.13%
2 Healthcare 24.19%
3 Financials 15.43%
4 Miscellaneous 9.08%
5 Materials 5.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WBD icon
1
Warner Bros
WBD
$70.3B
$256M 18.27%
22,254,967
+387,733
+2% +$5.27M
EQH icon
2
Equitable Holdings
EQH
$14.7B
$183M 13.04%
6,931,147
– –
T icon
3
AT&T
T
$183B
$161M 11.46%
10,468,715
– –
GTXAP
4
DELISTED
Garrett Motion Inc. Series A Cumulative Convertible Preferred Stock
GTXAP
$118M 8.42%
16,592,384
– –
HLN icon
5
Haleon
HLN
$40.6B
$104M 7.42%
+17,062,710
New +$110M
EMBC icon
6
Embecta
EMBC
$288M
$73.8M 5.27%
2,564,349
-1,061,435
-29% -$31.4M
AIV
7
Aimco
AIV
$333M
$72.5M 5.18%
9,932,043
– –
PRVB
8
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$67M 4.78%
14,879,023
+8,879,023
+148% +$40.5M
IFF icon
9
International Flavors & Fragrances
IFF
$21.5B
$63M 4.5%
694,043
– –
FLEX icon
10
Flex
FLEX
$39.9B
$41.6M 2.97%
3,317,500
– –
GTX icon
11
Garrett Motion
GTX
$4.78B
$39.1M 2.79%
6,912,204
– –
CRBG icon
12
Corebridge Financial
CRBG
$15.6B
$33.5M 2.39%
+1,702,152
New +$35M
PRMW
13
DELISTED
Primo Water Corporation
PRMW
$24.9M 1.78%
1,982,040
– –
VREX icon
14
Varex Imaging
VREX
$778M
$24M 1.72%
1,136,566
– –
CC icon
15
Chemours
CC
$2.21B
$20.2M 1.44%
818,717
-2,205,968
-73% -$72.8M
FDX icon
16
FedEx
FDX
$73B
$18.6M 1.32%
125,000
– –
NXPI icon
17
NXP Semiconductors
NXPI
$57.1B
$16.5M 1.18%
112,053
– –
EHAB
18
DELISTED
Enhabit
EHAB
$14M 1%
+1,000,000
New +$16.2M
PRTA icon
19
Prothena Corp
PRTA
$428M
$11.3M 0.81%
187,000
– –
APLS
20
DELISTED
Apellis Pharmaceuticals
APLS
$10.2M 0.73%
149,000
– –
RLAY icon
21
Relay Therapeutics
RLAY
$4.16B
$6.74M 0.48%
301,200
– –
ASND icon
22
Ascendis Pharma A/S
ASND
$15.8B
$6.04M 0.43%
58,500
– –
CLDX icon
23
Celldex Therapeutics
CLDX
$3.02B
$5.96M 0.43%
212,000
– –
DISH
24
DELISTED
DISH Network Corp.
DISH
$5.65M 0.4%
408,399
– –
BLCO icon
25
Bausch + Lomb
BLCO
$6.15B
$5.52M 0.39%
+360,000
New +$5.71M
1
2

Similar funds

DWM
Diversify Wealth Management Sandy, Utah $5.98B AUM 29.21% 1-Year Est. Return
DAS
Diversify Advisory Services Sandy, Utah $5.98B AUM 28.55% 1-Year Est. Return
AUB
Atlantic Union Bankshares Glen Allen, Virginia $5.99B AUM 23.66% 1-Year Est. Return
FMWA
Forvis Mazars Wealth Advisors Springfield, Missouri $5.99B AUM 21.91% 1-Year Est. Return
JPH
Japan Post Holdings Tokyo, Japan $5.97B AUM 11.18% 1-Year Est. Return
DRZID
DePrince Race & Zollo Inc (DRZ) Winter Park, Florida $5.96B AUM 38.5% 1-Year Est. Return
HW
Hancock Whitney Gulfport, Mississippi $6B AUM 34.57% 1-Year Est. Return
CIC
Crawford Investment Counsel Atlanta, Georgia $6B AUM 15.13% 1-Year Est. Return

Sessa Capital's Q3 2022 Portfolio in Review

As of Q3 2022, Sessa Capital held 37 positions worth $1.4B, down 24% from $1.83B the previous quarter. Its ten largest holdings account for 81% of the portfolio.

Sessa Capital deployed $43.7M of net new capital in Q3 2022, opening 4 new positions and adding to 2 existing holdings. Its largest new stake was Haleon: 17,062,710 shares worth $104M.

By sector, the portfolio is most concentrated in Communication Services at 30% of assets, up from 28% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Chemours, an estimated $72.8M trimmed.

  • Sessa Capital's largest Q3 2022 buy was Haleon: 17,062,710 shares worth $104M.
  • Sessa Capital added most to Provention Bio, Inc. Common Stock in Q3 2022, an estimated $40.5M increase.
  • Sessa Capital's biggest Q3 2022 reduction was Chemours, cutting an estimated $72.8M.
  • Sessa Capital fully exited Corteva in Q3 2022, selling an estimated $34.8M.
  • Sessa Capital's ten largest holdings make up 81% of its $1.4B portfolio in Q3 2022.
  • Sessa Capital opened 4 new positions and closed 6 in Q3 2022.
  • Sessa Capital's portfolio value fell 24% quarter-over-quarter to $1.4B.

Based on Sessa Capital's 13F filing for Q3 2022, filed 14 Nov 2022.